Alfonso G Zulueta
CIK 1596336 · SVP & President, Lilly Int'l · last filed 2025-11-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$72.18M
Companies
5
Total Filings
49
Lifetime Open-Market Net
-$17.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTS | Director | 35,913 | $66.13 | $2.37M | $99.6K | 10 | 2025-11-10 |
| Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted | Director | 133,301 | $0.01 | $773 | $0 | 1 | 2024-01-04 |
| Syneos Health, Inc. (SYNH) Delisted | Director | 4,863 | $42.98 | $209.0K | $0 | 4 | 2023-09-28 |
| AMRN | Director | — | $15.24 | — | $0 | 2 | 2022-06-29 |
| LLY | SVP & President, Lilly Int'l | 61,614 | $1133.00 | $69.81M | -$17.72M | 32 | 2021-02-10 |
Recent Filings · Page 4 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-04 | LLY | Sell (S) | −4,000 | -$480.0K | EDGAR |
| 2018-11-09 | CTS | Grant (A) | +4,200 | $121.2K | EDGAR |
| 2018-10-05 | LLY | Sell (S) | −7,000 | -$802.5K | EDGAR |
| 2018-09-19 | LLY | Sell (S) | −6,000 | -$637.8K | EDGAR |
| 2018-02-05 | LLY | Mixed | +8,860 | -$581.0K | EDGAR |
| 2018-01-31 | LLY | Grant (A) | +9,316 | $816.1K | EDGAR |
| 2017-12-05 | LLY | Sell (S) | −3,532 | -$303.8K | EDGAR |
| 2017-11-13 | LLY | Sell (S) | −2,003 | -$167.6K | EDGAR |
| 2017-02-08 | LLY | Sell (S) | −15,000 | -$1.16M | EDGAR |
| 2017-02-03 | LLY | Mixed | +3,532 | -$240.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.